Related Experiment Videos
Site-specific, catheter-based thrombolysis: a new technique for treating intracoronary thrombus and
1Department of Internal Medicine, Hartford Hospital, University of Connecticut 06115, USA.
Insights
Site-specific thrombolysis offers a promising new method for dissolving blood clots in coronary arteries. This technique uses local drug delivery, potentially reducing medication needed and improving patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Biomedical Engineering
Background:
- Intracoronary thrombus and thrombus-containing stenoses pose significant risks.
- Current treatments for coronary thrombus have limitations.
- Site-specific thrombolysis is an emerging catheter-based approach.
Purpose of the Study:
- To investigate the efficacy and safety of site-specific thrombolysis for intracoronary thrombus.
- To evaluate novel drug delivery systems for local thrombolytic therapy.
Main Methods:
- Local delivery of thrombolytic agents directly to intraluminal clot using catheter-based technology.
- Utilizing the Dispatch catheter and hydrogel-coated balloon systems.
- Preliminary studies involving 68 patients.
Main Results:
- Enhanced intracoronary thrombolysis observed with urokinase.
- Reduced dosage of urokinase compared to standard infusion protocols.
- Low complication rates reported with the new systems.
Conclusions:
- Site-specific thrombolysis demonstrates enhanced efficacy in dissolving coronary thrombus.
- New drug delivery systems show promise for reduced medication use and safety.
- Further multicenter randomized trials are warranted to compare local drug delivery with standard techniques.
Abstract:
Site-specific thrombolysis is a new technique for treating intracoronary thrombus and thrombus-containing stenoses that is currently under active investigation and that involves the local delivery of thrombolytic agents directly to intraluminal clot using catheter-based technology. The theoretic mechanisms of thrombolysis underlying this approach involves the "trapping" of thrombus in an environment of high thrombolytic drug concentration, mechanical disruption of intraluminal clot by the drug delivery catheter itself, and intramural deposition of lytic agents with the creation of a drug reservoir that may provide for prolonged local thrombolysis. To date, preliminary studies have documented enhanced local thrombolysis with urokinase using two new drug delivery systems--the Dispatch catheter and the hydrogel-coated balloon. In 68 patients that have been reported to date, use of these two new systems has resulted in enhanced intracoronary thrombolysis using much less urokinase than involved in standard infusion protocols, and with low complication rates. These preliminary observations will be further studied in two multicenter randomized protocols comparing local drug delivery with standard techniques for treating intracoronary thrombus.